Nwam LLC Alnylam Pharmaceuticals, Inc. Transaction History

Nwam LLC

$339 Million
Q2 2024

A detailed history of Nwam LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nwam LLC holds 852 shares of ALNY stock, worth $234,368. This represents 0.06% of its overall portfolio holdings.

Number of Shares

852

Holding current value

$234,368

% of portfolio

0.06%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 23, 2024	BUY	$143.31 - $247.0 $122,100 - $210,444	852 New	852 $207,000
Q4 2022 Feb 07, 2023	BUY	$185.53 - $241.31 $157,700 - $205,113	850 New	850 $202,000

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

Capital World Investors Los Angeles, CA

15M
Shares

$4.12 Billion
0.61% of portfolio
Vanguard Group Inc Valley Forge, PA

12.5M
Shares

$3.44 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.63 Billion
0.05% of portfolio
Wellington Management Group LLP Boston, MA

6.21M
Shares

$1.71 Billion
0.28% of portfolio
Baillie Gifford & CO

6.03M
Shares

$1.66 Billion
1.16% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account